Skip to Content
Merck
  • Reversal of resistance towards cisplatin by curcumin in cervical cancer cells.

Reversal of resistance towards cisplatin by curcumin in cervical cancer cells.

Asian Pacific journal of cancer prevention : APJCP (2014-03-13)
Madhumita Roy, Sutapa Mukherjee
ABSTRACT

Epigenetic regulators like histone deacetylases (1 and 2), and viral onco-proteins (E6/E7) are known to be overexpressed in cervical cancer cells. The present study was designed to investigate the effect of curcumin on HDACs (1 and 2) and HPV E6/E7 in the cervical cancer cell line SiHa and a drug resistant clone SiHaR (derived from SiHa). It was further intended to investigate whether curcumin could sensitize the cells towards cisplatin induced cell killing by modulation of multi drug resistant proteins like MRP1 and Pgp1. Curcumin inhibited HDACs, HPV expression and differentially increased acetylation and up-regulation of p53 in SiHa and SiHaR, leading to cell cycle arrest at G1-S phase. Up-regulation of pRb, p21, p27 and corresponding inhibition of cyclin D1 and CDK4 were observed. Cisplatin resistance in SiHaR due to over-expression of MRP1 and Pgp1 was overcome by curcumin. Curcumin also sensitized both the cervical cancer cells towards cisplatin induced cell killing. Inhibition of HDACs and HPVs led to cell cycle arrest at G1/S phase by alteration of cell cycle regulatory proteins. Suppression of MRP1 and Pgp1 by curcumin resulted in sensitization of cervical cancer cells, lowering the chemotherapeutic dose of the drug cisplatin.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-p53 Antibody, clone BP53-12, clone BP53-12, Upstate®, from mouse
Sigma-Aldrich
Anti-HDAC2 Antibody, clone 3F3, clone 3F3, Upstate®, from mouse
Sigma-Aldrich
Anti-acetyl-p53 (Lys320) Antibody, from rabbit, purified by affinity chromatography